PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25147615-0	2014	Discovery of Imigliptin, a Novel Selective DPP-4 Inhibitor for the Treatment of Type 2 Diabetes.	imigliptin	13-23	dipeptidyl peptidase 4	Homo sapiens	43-48	
34616361-0	2021	Dipeptidyl-Peptidase-IV Inhibitors, Imigliptin and Alogliptin, Improve Beta-Cell Function in Type 2 Diabetes.	imigliptin	36-46	dipeptidyl peptidase 4	Homo sapiens	0-23	
29952007-1	2018	Imigliptin is a novel DPP-4 inhibitor, designed to treat type 2 diabetes mellitus (T2DM).	imigliptin	0-10	dipeptidyl peptidase 4	Homo sapiens	22-27	
29803910-0	2018	Metabolites characterization of a novel DPP-4 inhibitor, imigliptin in humans and rats using ultra-high performance liquid chromatography coupled with synapt high-resolution mass spectrometry.	imigliptin	57-67	dipeptidyl peptidase 4	Homo sapiens	40-45	
29803910-1	2018	Imigliptin has been reported as a novel dipeptidyl-peptidase-IV (DPP-4) inhibitor to treat type 2 Diabetes Mellitus (T2DM), and is currently being tested in clinical trials.	imigliptin	0-10	dipeptidyl peptidase 4	Homo sapiens	40-63	
29803910-1	2018	Imigliptin has been reported as a novel dipeptidyl-peptidase-IV (DPP-4) inhibitor to treat type 2 Diabetes Mellitus (T2DM), and is currently being tested in clinical trials.	imigliptin	0-10	dipeptidyl peptidase 4	Homo sapiens	65-70	
29803910-2	2018	In the first human clinical study, imigliptin was well tolerated and proved to be a potent DPP-4 inhibitor.	imigliptin	35-45	dipeptidyl peptidase 4	Homo sapiens	91-96	
27108678-0	2016	Quantitative prediction of human pharmacokinetics and pharmacodynamics of imigliptin, a novel DPP-4 inhibitor, using allometric scaling, IVIVE and PK/PD modeling methods.	imigliptin	74-84	dipeptidyl peptidase 4	Homo sapiens	94-99	
27108678-1	2016	PURPOSE: To predict the pharmacokinetic/pharmacodynamic (PK/PD) profiles of imigliptin, a novel DPP-4 inhibitor, in first-in-human (FIH) study based on the data from preclinical species.	imigliptin	76-86	dipeptidyl peptidase 4	Homo sapiens	96-101